Ameriprise
LLY icon

Ameriprise’s Eli Lilly LLY Stock Holding History

Ameriprise’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,500
Closed -$3.47M – 4099
2024
Q4 		$3.47M Buy
4,500
+1,700
+61% +$1.41M ﹤0.01% 2617
2024
Q3 		$2.48M Buy
+2,800
New +$2.52M ﹤0.01% 2799

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise's LLY Position: Q1 2026 in Review

Ameriprise increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $98.5M and bringing the position to 2,984,392 shares worth $2.74B. The position accounts for 0.64% of the portfolio, ranked #20.

Ameriprise first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.1B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ameriprise held 2,984,392 shares of Eli Lilly worth $2.74B as of Q1 2026.
  • Ameriprise bought 97,128 Eli Lilly shares in Q1 2026, an estimated $98.5M.
  • Eli Lilly made up 0.64% of Ameriprise's portfolio in Q1 2026, its #20 holding.
  • Ameriprise first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Eli Lilly position peaked at $3.1B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.